Loading organizations...
Chord Capital operates as a venture capital investment company, focusing its strategic investments across a diverse array of deep technology and science-driven sectors. The firm specializes in providing capital to companies innovating within engineering, advanced materials, medical devices, physical and life sciences, telecommunications, energy, and electronics. It applies a hands-on approach, leveraging extensive market and technical expertise to support the growth of its portfolio companies.
The firm was founded in 1986 by partners John Townsend and David Farmer, establishing itself as an independent venture investor. Their vision was to identify and nurture nascent technological and scientific enterprises, providing crucial early-stage and growth capital. With bases in Cambridge and London, the founders aimed to bridge the gap between groundbreaking research and commercial viability, drawing on the UK's rich innovation ecosystem.
Chord Capital's typical portfolio comprises promising startups and scaling companies requiring patient capital and strategic guidance to bring their specialized products and services to market. The firm is dedicated to fostering long-term value creation by backing ventures poised to make significant impacts within their respective industries. Its enduring vision centers on building a robust portfolio that drives technological advancement and sustainable economic growth.
Chord Capital has 1 tracked investment across 1 company. The latest tracked deal is $20.0M Series A in uSens in June 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2016 | uSens | $20.0M Series A | Donghui PAN | ARM Innovation Ecosystem Accelerator, Fortune Capital, Great Capital, IResearch Capital, Wenli CUI |